202 related articles for article (PubMed ID: 6279206)
21. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
22. Some old and some new ideas on kinin metabolism.
Erdös EG
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S20-4. PubMed ID: 1697356
[TBL] [Abstract][Full Text] [Related]
23. Evidence for bradykinin potentiation by angiotensin congeners in conscious rats.
Textor SC; Brunner H; Gavras H
Am J Physiol; 1981 Feb; 240(2):H255-61. PubMed ID: 6258451
[TBL] [Abstract][Full Text] [Related]
24. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
Chen X; Pitt BR; Moalli R; Gillis CN
J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
26. Salivary kallikrein and kininase activities in periodontal diseases.
Picarelli A; Porcelli D; Porcelli G; Raffaelli R; Sacchi A; Volpe AR
Adv Exp Med Biol; 1986; 198 Pt B():433-7. PubMed ID: 3028080
[No Abstract] [Full Text] [Related]
27. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
28. Carboxypeptidases N (kininases I) in rat serum, lungs, liver and spleen and the inactivation of kinins (bradykinin).
Petàkovà M; Simonianovà E; Rybàk M
Physiol Bohemoslov; 1972 May; 21(3):287-93. PubMed ID: 4270022
[No Abstract] [Full Text] [Related]
29. Effects of mineralocorticoid on kininase activity along the distal nephron segments of the rat.
Tomita K; Ujiie K; Maeda Y; Iino Y; Yoshiyama N; Shiigai T
Adv Exp Med Biol; 1989; 247A():181-4. PubMed ID: 2557738
[No Abstract] [Full Text] [Related]
30. [Protaminase activity of plasma. III. Role of conversion enzyme (kininase II) in protaminase activity of plasma].
Blass J; Detruit H; Aime L; Fiancette JY; Gaillard M; Verriest C; Vicaigne MB; Weiss M
Pathol Biol (Paris); 1988 Dec; 36(10):1192-8. PubMed ID: 2853323
[TBL] [Abstract][Full Text] [Related]
31. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
Salgado HC; Carretero OA; Scicli AG; Murray RD
J Pharmacol Exp Ther; 1986 Apr; 237(1):204-8. PubMed ID: 2420968
[TBL] [Abstract][Full Text] [Related]
32. Bradykinin radioimmunoassay in plasma kininase determination.
Sipilä R; Torstila I
Adv Biosci; 1978 Jul; 17():183-6. PubMed ID: 755695
[No Abstract] [Full Text] [Related]
33. Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension.
Sharifi AM; Akbarloo N; Heshmatian B; Ziai A
Pharmacol Res; 2003 Mar; 47(3):201-9. PubMed ID: 12591015
[TBL] [Abstract][Full Text] [Related]
34. [Bradykinin-binding cell fractions. 3. Methods for determination of enzymatic degradation of bradykinin with kininase from plasma membranes].
Leisner H; Reissmann S; Arold H
Pharmazie; 1978 Aug; 33(8):531-3. PubMed ID: 724786
[No Abstract] [Full Text] [Related]
35. The kininase activity of Ehrlichs' ascites solid tumor after treatment with oncolytic clostridia.
Fischer G; Brantner H; Platzer P
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975 Oct; 84(2):203-6. PubMed ID: 171870
[TBL] [Abstract][Full Text] [Related]
36. [The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme].
Vernigora AN; Nikishin NN; Gengin MT
Biokhimiia; 1995 Jan; 60(1):144-9. PubMed ID: 7696431
[TBL] [Abstract][Full Text] [Related]
37. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
[TBL] [Abstract][Full Text] [Related]
38. Characterization and physiological role of angiotensin converting enzyme in rabbits lung.
Yoshida N
Jpn Circ J; 1979 Dec; 43(12):1135-6. PubMed ID: 232194
[No Abstract] [Full Text] [Related]
39. Carboxypeptidase N (kininase I) activity in blood and synovial fluid from patients with arthritis.
Chercuitte F; Beaulieu AD; Poubelle P; Marceau F
Life Sci; 1987 Sep; 41(10):1225-32. PubMed ID: 3041137
[TBL] [Abstract][Full Text] [Related]
40. Establishing the role of angiotensin-converting enzyme in renal function and blood pressure control through the analysis of genetically modified mice.
Bernstein KE; Xiao HD; Adams JW; Frenzel K; Li P; Shen XZ; Cole JM; Fuchs S
J Am Soc Nephrol; 2005 Mar; 16(3):583-91. PubMed ID: 15659560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
